{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:28:18Z","timestamp":1791156498076,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1750-1172-9-79","type":"journal-article","created":{"date-parts":[[2014,6,5]],"date-time":"2014-06-05T03:02:12Z","timestamp":1401937332000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Stilbenes and resveratrol metabolites improve mitochondrial fatty acid oxidation defects in human fibroblasts"],"prefix":"10.1186","volume":"9","author":[{"given":"Virginie","family":"Aires","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Delmas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Le Bachelier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Latruffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri","family":"Schlemmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Benoist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Djouadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Bastin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,5]]},"reference":[{"key":"763_CR1","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2174\/138945006776359331","volume":"7","author":"D Delmas","year":"2006","unstructured":"Delmas D, Lancon A, Colin D, Jannin B, Latruffe N: Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer. Curr Drug Targets. 2006, 7: 423-442. 10.2174\/138945006776359331.","journal-title":"Curr Drug Targets"},{"key":"763_CR2","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1248\/bpb.35.273","volume":"35","author":"R Nakata","year":"2012","unstructured":"Nakata R, Takahashi S, Inoue H: Recent advances in the study on resveratrol. Biol Pharm Bull. 2012, 35: 273-279. 10.1248\/bpb.35.273.","journal-title":"Biol Pharm Bull"},{"key":"763_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/nyas.12150","volume":"1290","author":"J Tome-Carneiro","year":"2013","unstructured":"Tome-Carneiro J, Gonzalvez M, Larrosa M, Yanez-Gascon MJ, Garcia-Almagro FJ, Ruiz-Ros JA, Tomas-Barberan FA, Garcia-Conesa MT, Espin JC: Resveratrol in primary and secondary prevention of cardiovascular disease: a dietary and clinical perspective. Ann N Y Acad Sci. 2013, 1290: 37-51. 10.1111\/nyas.12150.","journal-title":"Ann N Y Acad Sci"},{"key":"763_CR4","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature05354","volume":"444","author":"JA Baur","year":"2006","unstructured":"Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, Sinclair DA: Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006, 444: 337-342. 10.1038\/nature05354.","journal-title":"Nature"},{"key":"763_CR5","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.cell.2006.11.013","volume":"127","author":"M Lagouge","year":"2006","unstructured":"Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J: Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell. 2006, 127: 1109-1122. 10.1016\/j.cell.2006.11.013.","journal-title":"Cell"},{"key":"763_CR6","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1113\/jphysiol.2012.230490","volume":"590","author":"VW Dolinsky","year":"2012","unstructured":"Dolinsky VW, Jones KE, Sidhu RS, Haykowsky M, Czubryt MP, Gordon T, Dyck JR: Improvements in skeletal muscle strength and cardiac function induced by resveratrol during exercise training contribute to enhanced exercise performance in rats. J Physiol. 2012, 590: 2783-2799. 10.1113\/jphysiol.2012.230490.","journal-title":"J Physiol"},{"key":"763_CR7","doi-asserted-by":"publisher","first-page":"525094","DOI":"10.1155\/2011\/525094","volume":"2011","author":"E Tauriainen","year":"2011","unstructured":"Tauriainen E, Luostarinen M, Martonen E, Finckenberg P, Kovalainen M, Huotari A, Herzig KH, Lecklin A, Mervaala E: Distinct effects of calorie restriction and resveratrol on diet-induced obesity and fatty liver formation. J Nutr Metab. 2011, 2011: 525094.","journal-title":"J Nutr Metab"},{"key":"763_CR8","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.jnutbio.2010.07.007","volume":"22","author":"J Mercader","year":"2011","unstructured":"Mercader J, Palou A, Bonet ML: Resveratrol enhances fatty acid oxidation capacity and reduces resistin and retinol-binding protein 4 expression in white adipocytes. J Nutr Biochem. 2011, 22: 828-834. 10.1016\/j.jnutbio.2010.07.007.","journal-title":"J Nutr Biochem"},{"key":"763_CR9","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.cell.2012.01.017","volume":"148","author":"SJ Park","year":"2012","unstructured":"Park SJ, Ahmad F, Philp A, Baar K, Williams T, Luo H, Ke H, Rehmann H, Taussig R, Brown AL, Kim MK, Beaven MA, Burgin AB, Manganiello V, Chung JH: Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell. 2012, 148: 421-433. 10.1016\/j.cell.2012.01.017.","journal-title":"Cell"},{"key":"763_CR10","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.cmet.2012.04.003","volume":"15","author":"NL Price","year":"2012","unstructured":"Price NL, Gomes AP, Ling AJ, Duarte FV, Martin-Montalvo A, North BJ, Agarwal B, Ye L, Ramadori G, Teodoro JS, Hubbard BP, Varela AT, Davis JG, Varamini B, Hafner A, Moaddel R, Rolo AP, Coppari R, Palmeira CM, de Cabo R, Baur JA, Sinclair DA: SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab. 2012, 15: 675-690. 10.1016\/j.cmet.2012.04.003.","journal-title":"Cell Metab"},{"key":"763_CR11","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s10545-008-0990-y","volume":"31","author":"N Gregersen","year":"2008","unstructured":"Gregersen N, Andresen BS, Pedersen CB, Olsen RK, Corydon TJ, Bross P: Mitochondrial fatty acid oxidation defects\u2013remaining challenges. J Inherit Metab Dis. 2008, 31: 643-657. 10.1007\/s10545-008-0990-y.","journal-title":"J Inherit Metab Dis"},{"key":"763_CR12","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s10545-013-9611-5","volume":"36","author":"SE Olpin","year":"2013","unstructured":"Olpin SE: Pathophysiology of fatty acid oxidation disorders and resultant phenotypic variability. J Inherit Metab Dis. 2013, 36: 645-658. 10.1007\/s10545-013-9611-5.","journal-title":"J Inherit Metab Dis"},{"key":"763_CR13","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.mam.2004.06.004","volume":"25","author":"JP Bonnefont","year":"2004","unstructured":"Bonnefont JP, Djouadi F, Prip-Buus C, Gobin S, Munnich A, Bastin J: Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects. Mol Aspects Med. 2004, 25: 495-520. 10.1016\/j.mam.2004.06.004.","journal-title":"Mol Aspects Med"},{"key":"763_CR14","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1086\/522375","volume":"81","author":"S Gobin-Limballe","year":"2007","unstructured":"Gobin-Limballe S, Djouadi F, Aubey F, Olpin S, Andresen BS, Yamaguchi S, Mandel H, Fukao T, Ruiter JP, Wanders RJ, McAndrew R, Kim JJ, Bastin J: Genetic basis for correction of very-long-chain acyl-coenzyme A dehydrogenase deficiency by bezafibrate in patient fibroblasts: toward a genotype-based therapy. Am J Hum Genet. 2007, 81: 1133-1143. 10.1086\/522375.","journal-title":"Am J Hum Genet"},{"key":"763_CR15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/clpt.2010.55","volume":"88","author":"JP Bonnefont","year":"2010","unstructured":"Bonnefont JP, Bastin J, Laforet P, Aubey F, Mogenet A, Romano S, Ricquier D, Gobin-Limballe S, Vassault A, Behin A, Eymard B, Bresson JL, Djouadi F: Long-term follow-up of bezafibrate treatment in patients with the myopathic form of carnitine palmitoyltransferase 2 deficiency. Clin Pharmacol Ther. 2010, 88: 101-108. 10.1038\/clpt.2010.55.","journal-title":"Clin Pharmacol Ther"},{"key":"763_CR16","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10545-008-0844-7","volume":"31","author":"F Djouadi","year":"2008","unstructured":"Djouadi F, Bastin J: PPARs as therapeutic targets for correction of inborn mitochondrial fatty acid oxidation disorders. J Inherit Metab Dis. 2008, 31: 217-225. 10.1007\/s10545-008-0844-7.","journal-title":"J Inherit Metab Dis"},{"key":"763_CR17","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1093\/hmg\/ddr089","volume":"20","author":"J Bastin","year":"2011","unstructured":"Bastin J, Lopes-Costa A, Djouadi F: Exposure to resveratrol triggers pharmacological correction of fatty acid utilization in human fatty acid oxidation-deficient fibroblasts. Hum Mol Genet. 2011, 20: 2048-2057. 10.1093\/hmg\/ddr089.","journal-title":"Hum Mol Genet"},{"key":"763_CR18","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1749-6632.2010.05853.x","volume":"1215","author":"KR Patel","year":"2011","unstructured":"Patel KR, Scott E, Brown VA, Gescher AJ, Steward WP, Brown K: Clinical trials of resveratrol. Ann N Y Acad Sci. 2011, 1215: 161-169. 10.1111\/j.1749-6632.2010.05853.x.","journal-title":"Ann N Y Acad Sci"},{"key":"763_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/mnfr.200900437","volume":"54","author":"CH Cottart","year":"2010","unstructured":"Cottart CH, Nivet-Antoine V, Laguillier-Morizot C, Beaudeux JL: Resveratrol bioavailability and toxicity in humans. Mol Nutr Food Res. 2010, 54: 7-16. 10.1002\/mnfr.200900437.","journal-title":"Mol Nutr Food Res"},{"key":"763_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1749-6632.2010.05842.x","volume":"1215","author":"T Walle","year":"2011","unstructured":"Walle T: Bioavailability of resveratrol. Ann N Y Acad Sci. 2011, 1215: 9-15. 10.1111\/j.1749-6632.2010.05842.x.","journal-title":"Ann N Y Acad Sci"},{"key":"763_CR21","doi-asserted-by":"publisher","first-page":"5033","DOI":"10.1021\/jm100274c","volume":"53","author":"J Hoshino","year":"2010","unstructured":"Hoshino J, Park EJ, Kondratyuk TP, Marler L, Pezzuto JM, van Breemen RB, Mo S, Li Y, Cushman M: Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites. J Med Chem. 2010, 53: 5033-5043. 10.1021\/jm100274c.","journal-title":"J Med Chem"},{"key":"763_CR22","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1002\/mnfr.201100065","volume":"55","author":"D Delmas","year":"2011","unstructured":"Delmas D, Lin HY: Role of membrane dynamics processes and exogenous molecules in cellular resveratrol uptake: consequences in bioavailability and activities. Mol Nutr Food Res. 2011, 55: 1142-1153. 10.1002\/mnfr.201100065.","journal-title":"Mol Nutr Food Res"},{"key":"763_CR23","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.bbrc.2004.02.164","volume":"316","author":"A Lancon","year":"2004","unstructured":"Lancon A, Delmas D, Osman H, Thenot JP, Jannin B, Latruffe N: Human hepatic cell uptake of resveratrol: involvement of both passive diffusion and carrier-mediated process. Biochem Biophys Res Commun. 2004, 316: 1132-1137. 10.1016\/j.bbrc.2004.02.164.","journal-title":"Biochem Biophys Res Commun"},{"key":"763_CR24","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1042\/BJ20091857","volume":"429","author":"B Calamini","year":"2010","unstructured":"Calamini B, Ratia K, Malkowski MG, Cuendet M, Pezzuto JM, Santarsiero BD, Mesecar AD: Pleiotropic mechanisms facilitated by resveratrol and its metabolites. Biochem J. 2010, 429: 273-282. 10.1042\/BJ20091857.","journal-title":"Biochem J"},{"key":"763_CR25","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1203\/01.PDR.0000083001.91588.BB","volume":"54","author":"F Djouadi","year":"2003","unstructured":"Djouadi F, Bonnefont JP, Thuillier L, Droin V, Khadom N, Munnich A, Bastin J: Correction of fatty acid oxidation in carnitine palmitoyl transferase 2-deficient cultured skin fibroblasts by bezafibrate. Pediatr Res. 2003, 54: 446-451. 10.1203\/01.PDR.0000083001.91588.BB.","journal-title":"Pediatr Res"},{"key":"763_CR26","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1093\/hmg\/ddi303","volume":"14","author":"F Djouadi","year":"2005","unstructured":"Djouadi F, Aubey F, Schlemmer D, Ruiter JP, Wanders RJ, Strauss AW, Bastin J: Bezafibrate increases very-long-chain acyl-CoA dehydrogenase protein and mRNA expression in deficient fibroblasts and is a potential therapy for fatty acid oxidation disorders. Hum Mol Genet. 2005, 14: 2695-2703. 10.1093\/hmg\/ddi303.","journal-title":"Hum Mol Genet"},{"key":"763_CR27","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jchromb.2006.10.017","volume":"848","author":"DJ Boocock","year":"2007","unstructured":"Boocock DJ, Patel KR, Faust GE, Normolle DP, Marczylo TH, Crowell JA, Brenner DE, Booth TD, Gescher A, Steward WP: Quantitation of trans-resveratrol and detection of its metabolites in human plasma and urine by high performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci. 2007, 848: 182-187. 10.1016\/j.jchromb.2006.10.017.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"763_CR28","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1017\/S0007114507882997","volume":"100","author":"R Zamora-Ros","year":"2008","unstructured":"Zamora-Ros R, Andres-Lacueva C, Lamuela-Raventos RM, Berenguer T, Jakszyn P, Martinez C, Sanchez MJ, Navarro C, Chirlaque MD, Tormo MJ, Quiros JR, Amiano P, Dorronsoro M, Larranaga N, Barricarte A, Ardanaz E, Gonzalez CA: Concentrations of resveratrol and derivatives in foods and estimation of dietary intake in a Spanish population: European prospective investigation into cancer and nutrition (EPIC)-Spain cohort. Br J Nutr. 2008, 100: 188-196.","journal-title":"Br J Nutr"},{"key":"763_CR29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.mito.2006.11.017","volume":"7","author":"D Kang","year":"2007","unstructured":"Kang D, Kim SH, Hamasaki N: Mitochondrial transcription factor A (TFAM): roles in maintenance of mtDNA and cellular functions. Mitochondrion. 2007, 7: 39-44. 10.1016\/j.mito.2006.11.017.","journal-title":"Mitochondrion"},{"key":"763_CR30","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1124\/dmd.106.013664","volume":"35","author":"A Lancon","year":"2007","unstructured":"Lancon A, Hanet N, Jannin B, Delmas D, Heydel JM, Lizard G, Chagnon MC, Artur Y, Latruffe N: Resveratrol in human hepatoma HepG2 cells: metabolism and inducibility of detoxifying enzymes. Drug Metab Dispos. 2007, 35: 699-703. 10.1124\/dmd.106.013664.","journal-title":"Drug Metab Dispos"},{"key":"763_CR31","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/j.1600-0625.2012.01486.x","volume":"21","author":"C Gotz","year":"2012","unstructured":"Gotz C, Pfeiffer R, Tigges J, Blatz V, Jackh C, Freytag EM, Fabian E, Landsiedel R, Merk HF, Krutmann J, Edwards RJ, Pease C, Goebel C, Hewitt N, Fritsche E: Xenobiotic metabolism capacities of human skin in comparison with a 3D epidermis model and keratinocyte-based cell culture as in vitro alternatives for chemical testing: activating enzymes (Phase I). Exp Dermatol. 2012, 21: 358-363. 10.1111\/j.1600-0625.2012.01486.x.","journal-title":"Exp Dermatol"},{"key":"763_CR32","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1600-0625.2012.01478.x","volume":"21","author":"C Gotz","year":"2012","unstructured":"Gotz C, Pfeiffer R, Tigges J, Ruwiedel K, Hubenthal U, Merk HF, Krutmann J, Edwards RJ, Abel J, Pease C, Goebel C, Hewitt N, Fritsche E: Xenobiotic metabolism capacities of human skin in comparison with a 3D-epidermis model and keratinocyte-based cell culture as in vitro alternatives for chemical testing: phase II enzymes. Exp Dermatol. 2012, 21: 364-369. 10.1111\/j.1600-0625.2012.01478.x.","journal-title":"Exp Dermatol"},{"key":"763_CR33","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1080\/03602530701690366","volume":"39","author":"F Oesch","year":"2007","unstructured":"Oesch F, Fabian E, Oesch-Bartlomowicz B, Werner C, Landsiedel R: Drug-metabolizing enzymes in the skin of man, rat, and pig. Drug Metab Rev. 2007, 39: 659-698. 10.1080\/03602530701690366.","journal-title":"Drug Metab Rev"},{"key":"763_CR34","volume-title":"Drug Metab Rev","author":"AM Sharma","year":"2013","unstructured":"Sharma AM, Uetrecht J: Bioactivation of drugs in the skin: relationship to cutaneous adverse drug reactions. Drug Metab Rev. 2013."},{"key":"763_CR35","doi-asserted-by":"publisher","first-page":"3348","DOI":"10.1021\/jp9115996","volume":"114","author":"P Bourassa","year":"2010","unstructured":"Bourassa P, Kanakis CD, Tarantilis P, Pollissiou MG, Tajmir-Riahi HA: Resveratrol, genistein, and curcumin bind bovine serum albumin. J Phys Chem B. 2010, 114: 3348-3354. 10.1021\/jp9115996.","journal-title":"J Phys Chem B"},{"key":"763_CR36","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1002\/mnfr.201100122","volume":"55","author":"TP Kondratyuk","year":"2011","unstructured":"Kondratyuk TP, Park EJ, Marler LE, Ahn S, Yuan Y, Choi Y, Yu R, van Breemen RB, Sun B, Hoshino J, Cushman M, Jermihov KC, Mesecar AD, Grubbs CJ, Pezzuto JM: Resveratrol derivatives as promising chemopreventive agents with improved potency and selectivity. Mol Nutr Food Res. 2011, 55: 1249-1265. 10.1002\/mnfr.201100122.","journal-title":"Mol Nutr Food Res"},{"key":"763_CR37","doi-asserted-by":"publisher","first-page":"e26391","DOI":"10.1371\/journal.pone.0026391","volume":"6","author":"S Rimbaud","year":"2011","unstructured":"Rimbaud S, Ruiz M, Piquereau J, Mateo P, Fortin D, Veksler V, Garnier A, Ventura-Clapier R: Resveratrol improves survival, hemodynamics and energetics in a rat model of hypertension leading to heart failure. PLoS One. 2011, 6: e26391-10.1371\/journal.pone.0026391.","journal-title":"PLoS One"},{"key":"763_CR38","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.cmet.2011.10.002","volume":"14","author":"S Timmers","year":"2011","unstructured":"Timmers S, Konings E, Bilet L, Houtkooper RH, van de Weijer T, Goossens GH, Hoeks J, van der Krieken S, Ryu D, Kersten S, Moonen-Kornips E, Hesselink MK, Kunz I, Schrauwen-Hinderling VB, Blaak EE, Auwerx J, Schrauwen P: Calorie restriction-like effects of 30\u00a0days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab. 2011, 14: 612-622. 10.1016\/j.cmet.2011.10.002.","journal-title":"Cell Metab"},{"key":"763_CR39","doi-asserted-by":"publisher","first-page":"6968","DOI":"10.1074\/jbc.M112.431155","volume":"288","author":"KJ Menzies","year":"2013","unstructured":"Menzies KJ, Singh K, Saleem A, Hood DA: Sirtuin 1-mediated effects of exercise and resveratrol on mitochondrial biogenesis. J Biol Chem. 2013, 288: 6968-6979. 10.1074\/jbc.M112.431155.","journal-title":"J Biol Chem"},{"key":"763_CR40","doi-asserted-by":"publisher","first-page":"H13","DOI":"10.1152\/ajpheart.00368.2009","volume":"297","author":"A Csiszar","year":"2009","unstructured":"Csiszar A, Labinskyy N, Pinto JT, Ballabh P, Zhang H, Losonczy G, Pearson K, de Cabo R, Pacher P, Zhang C, Ungvari Z: Resveratrol induces mitochondrial biogenesis in endothelial cells. Am J Physiol Heart Circ Physiol. 2009, 297: H13-20. 10.1152\/ajpheart.00368.2009.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"763_CR41","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1093\/hmg\/ddt603","volume":"23","author":"A Lopes Costa","year":"2014","unstructured":"Lopes Costa A, Le Bachelier C, Mathieu L, Rotig A, Boneh A, De Lonlay P, Tarnopolsky MA, Thorburn DR, Bastin J, Djouadi F: Beneficial effects of resveratrol on respiratory chain defects in patients\u2019 fibroblasts involve estrogen receptor and estrogen-related receptor alpha signaling. Hum Mol Genet. 2014, 23: 2106-2119. 10.1093\/hmg\/ddt603.","journal-title":"Hum Mol Genet"},{"issue":"Suppl","key":"763_CR42","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1016\/j.ymgme.2013.10.007","volume":"110","author":"RK Olsen","year":"2013","unstructured":"Olsen RK, Cornelius N, Gregersen N: Genetic and cellular modifiers of oxidative stress: what can we learn from fatty acid oxidation defects?. Mol Genet Metab. 2013, 110 (Suppl): S31-39.","journal-title":"Mol Genet Metab"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-1172-9-79.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T04:05:53Z","timestamp":1630555553000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/1750-1172-9-79"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,5]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["763"],"URL":"https:\/\/doi.org\/10.1186\/1750-1172-9-79","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,5]]},"assertion":[{"value":"20 February 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"79"}}